Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses. Caster O, Edwards RI BMC Neurol. 2015; 15(1):206. Epub 2015 Oct 16. PMID: 26475456. Abstract CommentRecommendBookmarkWatch